Skip to content

Investigator

Wei-Jun Qian

BATTELLE PACIFIC NORTHWEST LABORATORIES · funded by NIDDK

Companies
3

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$5.0M

Summed across those awards.

First award
Jul 21, 2023

Latest May 1, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. U01

    Discovery of Pathways and Molecular Mediators of Early T1D Pathogenesis using Spatial Multi-Omics

    $3.1M

    May 1, 2026NIDDKBATTELLE PACIFIC NORTHWEST LABORATORIESNIH RePORTER · 11135130 (opens the source filing in a new tab)

  2. U01

    Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications

    $930k

    Jul 21, 2023NIDDKBATTELLE PACIFIC NORTHWEST LABORATORIESNIH RePORTER · 11120936 (opens the source filing in a new tab)

  3. U01

    Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications

    $915k

    Jul 21, 2023NIDDKBATTELLE PACIFIC NORTHWEST LABORATORIESNIH RePORTER · 11335733 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources